NCT04769076 2021-02-25
The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
Clinical Trials
8 trialsNCT04766359 2021-02-23
Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3 Unknown
NCT03656965 2018-09-04
EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug
Kuwait Cancer Control Center
Phase 3 Unknown
NCT03344068 2017-12-22
Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2/3 Unknown
NCT03045484 2017-11-29
Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy
Sun Yat-sen University
Phase NA Unknown
NCT03058432 2017-02-23
Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02633176 2015-12-17
Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT02500940 2015-07-17
Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
Taichung Veterans General Hospital
Phase 3 Unknown